164 related articles for article (PubMed ID: 30631793)
1. Impact of Diabetes Mellitus on the Presentation and Response to Treatment of Adults With Pulmonary Tuberculosis in Qatar.
Dousa KM; Hamad A; Albirair M; Al Soub H; Elzouki AN; Alwakeel MI; Thiel BA; Johnson JL
Open Forum Infect Dis; 2019 Jan; 6(1):ofy335. PubMed ID: 30631793
[TBL] [Abstract][Full Text] [Related]
2. Comparison of acid fast bacilli (AFB) smear for
Fachri M; Hatta M; Abadi S; Santoso SS; Wikanningtyas TA; Syarifuddin A; Dwiyanti R; Noviyanthi RA
Respir Med Case Rep; 2018; 23():158-162. PubMed ID: 29719807
[TBL] [Abstract][Full Text] [Related]
3. Fixed-dose combination associated with faster time to smear conversion compared to separate tablets of anti-tuberculosis drugs in patients with poorly controlled diabetes and pulmonary tuberculosis in Qatar.
Al-Shaer MH; Elewa H; Alkabab Y; Nazer LH; Heysell SK
BMC Infect Dis; 2018 Aug; 18(1):384. PubMed ID: 30089476
[TBL] [Abstract][Full Text] [Related]
4. Sputum smear conversion and treatment outcomes for tuberculosis patients with and without diabetes in Fiji.
Prasad P; Gounder S; Varman S; Viney K
Public Health Action; 2014 Sep; 4(3):159-63. PubMed ID: 26400803
[TBL] [Abstract][Full Text] [Related]
5. Clinicoradiological Profile of Patients Having Drug-Sensitive Pulmonary Tuberculosis With and Without Diabetes Mellitus in a Tertiary Care Hospital in Ahmedabad, Gujarat, India.
Barot A; Vora A; Dobariya O; Parikh V; Rahumath S L; Shah N; Borisagar G
Cureus; 2024 Apr; 16(4):e58810. PubMed ID: 38784356
[TBL] [Abstract][Full Text] [Related]
6. Sputum conversion at the end of intensive phase of Category-1 regimen in the treatment of pulmonary tuberculosis patients with diabetes mellitus or HIV infection: An analysis of risk factors.
Banu Rekha VV; Balasubramanian R; Swaminathan S; Ramachandran R; Rahman F; Sundaram V; Thyagarajan K; Selvakumar N; Adhilakshmi AR; Iliayas S; Narayanan PR
Indian J Med Res; 2007 Nov; 126(5):452-8. PubMed ID: 18160750
[TBL] [Abstract][Full Text] [Related]
7. [Tuberculosis in compromised hosts].
Kekkaku; 2003 Nov; 78(11):717-22. PubMed ID: 14672050
[TBL] [Abstract][Full Text] [Related]
8. Clinical features, immunologic parameter and treatment outcome of Chinese tuberculosis patients with or without DM.
Tong F; Lai J; Lu Z; Bao Z; Cao J
Front Med (Lausanne); 2024; 11():1386124. PubMed ID: 38933114
[TBL] [Abstract][Full Text] [Related]
9. API TB Consensus Guidelines 2006: Management of pulmonary tuberculosis, extra-pulmonary tuberculosis and tuberculosis in special situations.
API Consensus Expert Committee
J Assoc Physicians India; 2006 Mar; 54():219-34. PubMed ID: 16800350
[TBL] [Abstract][Full Text] [Related]
10. Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.
Johnson JL; Vjecha MJ; Okwera A; Hatanga E; Byekwaso F; Wolski K; Aisu T; Whalen CC; Huebner R; Mugerwa RD; Ellner JJ
Int J Tuberc Lung Dis; 1998 May; 2(5):397-404. PubMed ID: 9613636
[TBL] [Abstract][Full Text] [Related]
11. The effect of metformin on culture conversion in tuberculosis patients with diabetes mellitus.
Lee YJ; Han SK; Park JH; Lee JK; Kim DK; Chung HS; Heo EY
Korean J Intern Med; 2018 Sep; 33(5):933-940. PubMed ID: 29540054
[TBL] [Abstract][Full Text] [Related]
12. Response to empirical anti-tuberculosis treatment in patients with sputum smear-negative presumptive pulmonary tuberculosis.
Lee CH; Kim WJ; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
Respiration; 2005; 72(4):369-74. PubMed ID: 16088279
[TBL] [Abstract][Full Text] [Related]
13. Factors influencing sputum smear and culture conversion time among patients with new case pulmonary tuberculosis.
Güler M; Unsal E; Dursun B; Aydln O; Capan N
Int J Clin Pract; 2007 Feb; 61(2):231-5. PubMed ID: 17166185
[TBL] [Abstract][Full Text] [Related]
14. Diabetes mellitus, smoking status, and rate of sputum culture conversion in patients with multidrug-resistant tuberculosis: a cohort study from the country of Georgia.
Magee MJ; Kempker RR; Kipiani M; Tukvadze N; Howards PP; Narayan KM; Blumberg HM
PLoS One; 2014; 9(4):e94890. PubMed ID: 24736471
[TBL] [Abstract][Full Text] [Related]
15. Risk factors in patients with AFB smear-positive sputum who receive inappropriate antituberculous treatment.
Chang CY; Hong JY; Yuan MK; Chang SJ; Lee YM; Chang SC; Hsu LC; Cheng SL
Drug Des Devel Ther; 2013; 7():53-8. PubMed ID: 23386785
[TBL] [Abstract][Full Text] [Related]
16. Severe pulmonary radiological manifestations are associated with a distinct biochemical profile in blood of tuberculosis patients with dysglycemia.
Barreda NN; Arriaga MB; Aliaga JG; Lopez K; Sanabria OM; Carmo TA; Fróes Neto JF; Lecca L; Andrade BB; Calderon RI
BMC Infect Dis; 2020 Feb; 20(1):139. PubMed ID: 32059707
[TBL] [Abstract][Full Text] [Related]
17. Diabetes mellitus and tuberculosis: pattern of tuberculosis, two-month smear conversion and treatment outcomes in Guangzhou, China.
Mi F; Tan S; Liang L; Harries AD; Hinderaker SG; Lin Y; Yue W; Chen X; Liang B; Gong F; Du J
Trop Med Int Health; 2013 Nov; 18(11):1379-85. PubMed ID: 24112411
[TBL] [Abstract][Full Text] [Related]
18. The Footprint of Diabetes Mellitus on the Characteristics and Response to Anti-Tuberculous Therapy in Patients with Pulmonary Tuberculosis from Saudi Arabia.
Abd El-Hamid El-Kady R; Abdulrahman Turkistani S
Infect Drug Resist; 2021; 14():5303-5312. PubMed ID: 34916814
[TBL] [Abstract][Full Text] [Related]
19. Clinical significance of smear positivity for acid-fast bacilli after ≥5 months of treatment in patients with drug-susceptible pulmonary tuberculosis.
Kang HK; Jeong BH; Lee H; Park HY; Jeon K; Huh HJ; Ki CS; Lee NY; Koh WJ
Medicine (Baltimore); 2016 Aug; 95(31):e4540. PubMed ID: 27495111
[TBL] [Abstract][Full Text] [Related]
20. Changes of CRP serum levels in pulmonary TB patients with AFB smear-positive sputum before and two months after receiving anti-tuberculosis drug treatment.
Soedarsono S; Subiantoro MC
Indian J Tuberc; 2019 Jan; 66(1):134-138. PubMed ID: 30797271
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
